Effect of High Dose Intravenous Vitamin C in Severe Pneumonia

Summary

This trial is a multicenter, randomized, double-blind, two-arm, parallel-group, placebo-controlled trial to investigate the effect of high dose intravenous (IV) Vitamin C as an adjunct to the standard of care for patients with severe pneumonia versus placebo in ICU.

Timeline

Start

2024-01-12

Primary completion

2025-12

Completion

2026-02

Drugs

Indications